- Filed
- Nov 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 4, 2025 | 15.01M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 14.53M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 14.47M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 14.32M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 14.29M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $1.94M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $402K |
| Capex | Q3 2025 · Sep 30, 2025 | $839K |
| Capex | Q3 2025 · Sep 30, 2024 | $1.28M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $28.11M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $21.84M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $161.36M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $168.6M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $2.98M |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $2.98M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $19.92M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $12.32M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $180.36M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $173.17M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $168.7M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $171.99M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | $179.78M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | $183.97M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $53.75M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $52.98M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $219.05M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $225.74M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $102.57M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $90.27M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $399.41M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $394.43M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.37 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $0.58 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.61 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$1.04 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.37 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.58 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.61 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$1.04 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $19.42M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $56.96M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $19.38M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $57.65M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $8.17M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $24.53M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $7.74M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $26.63M |
| Net Income | Q3 2025 · Sep 30, 2025 | $5.6M |
| Net Income | Q3 2025 · Sep 30, 2025 | $8.64M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$9.15M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$15.39M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $4.07M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $15.86M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $2.81M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | $76K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $42.05M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $122.83M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $42.37M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $127.47M |
| Revenue | Q3 2025 · Sep 30, 2025 | $86.11M |
| Revenue | Q3 2025 · Sep 30, 2025 | $259.04M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $84.7M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $254.42M |